Indee Labs
Enabling T cell immunotherapy discovery, development and manufacturing
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
- Website
- indeelabs.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2017
- Team
- 5 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run indeelabs.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Indee Labs across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Indee Labs's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
